15 Sep, 2021, 08:00 ET. BOTHELL, Wash., Sept. 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS ) ("BioLife" or the "Company"), a leading developer and supplier of class-defining ...View BioLife Solutions, Inc BLFS investment & stock information. Get the latest BioLife Solutions, Inc BLFS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.WebSexton's 2021 revenue contribution is expected to be approximately $2 million, based on an anticipated closing date of September 1st. BioLife 2021 total revenue is expected to be in a range of ...Web$12.75. As on 28-Nov-2023 16:00 EST. up-down-arrow $-0.69 • -5.13% · Prev Close info. $13.44 · Day's Open info. $13.38 · Today's High info. $13.55 · Today's Low ...BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced ...WebNowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking.BioLife Solutions Reports Third Quarter 2023 Financial Results Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash., Nov. 9, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell ...0001354488-12-003014.txt : 20120601 0001354488-12-003014.hdr.sgml : 20120601 20120601150827 accession number: 0001354488-12-003014 conformed submission type: 8-k public document count: 2 conformed period of report: 20120530 item information: entry into a material definitive agreement item information: other events item information: financial …BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.WebMar 13, 2023 · BioLife Solutions, Inc. (BLFS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the ... Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disordersGet BioLife Solutions Inc (BLFS.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsBiolife Solutions Return On Asset is currently at (5.67)%. Return on Asset or ROA shows how effective is the management of the Biolife Solutions in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of Biolife Solutions as well as to understand management …Get the latest BioLife Solutions, Inc. (BLFS) stock quote, history, news and other vital information to help you with your stock trading and investing. See the company's performance outlook, earnings date, dividend and yield, fair value, ratings and more.Under the terms of the agreement, BioLife will pay $15 million in cash and $15 million in newly issued shares of BioLife common stock for 100% of the outstanding shares of SciSafe. SciSafe's shareholders are also eligible over the next four years to receive up to 626,000 additional shares of BioLife common stock based on the achievement of ...Four times named as one of the top 100 Companies to work for in Washington state (2022, 2020, 2015, and 2013), BioLife Solutions Inc. is a multi-platform provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets. Learn more. B. Riley FBR analyst Marc Wiesenberger resumed coverage of BioLife stock with a Buy rating and a price target of $27 per share, representing a 94.6% premium to Thursday's closing price. As cell ...Nov 30, 2023 · See the latest BioLife Solutions Inc stock price (BLFS:XNAS), related news, valuation, dividends and more to help you make your investing decisions. BioLife Solutions was up solidly in Monday’s trading session on positive results from a Phase 3 study. ... Stock Market News. Economic News. Morning Brief. Personal Finance. Crypto News.See the latest Biolife Sciences Inc stock price (BLFE:PINX), related news, valuation, dividends and more to help you make your investing decisions.BioLife Solutions, Inc. (NasdaqCM:BLFS) entered into a definitive agreement and plan of merger to acquire Global Cooling, Inc. for approximately $270 million on March 19, 2021. Under the terms of the transaction, BioLife will issue 6.65 million shares of its common stock. The consideration also include the assumption of $8.7 million debt.WebBioLife Solutions, Inc. : News, information and stories for BioLife Solutions, Inc. | Other OTC: | Other OTCCurrent. N/A. 1 Month Ago. N/A. 3 Months Ago. N/A. BioLife Sciences Inc. analyst estimates, including BLFE earnings per share estimates and analyst recommendations.BOTHELL, Wash., Nov. 9, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced financial results for the three and nine months …WebGet the latest Takeda Pharmaceutical Co Ltd (TAK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Mar 13, 2023 · BioLife Solutions, Inc. (BLFS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the ... BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38 ... Biolife Solutions Inc (NASDAQ:BLFS) has a beta value of 1.60 and has seen 2.24 million shares traded in the last trading session. The company, currently valued at $596.91M, closed the last trade at $13.25 per share which meant it gained $0.88 on the day or 7.11% during that session. The BLFS stock ...Step 3: Place a buy order. After identifying a stock or ETF you want to add to your portfolio, place a buy order through your brokerage account. While most brokers offer a wide range of order types, the two most common orders you'll use to buy and sell growth stocks are market orders and limit orders.BLFE | Complete BioLife Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. BioLife Solutions, Inc. announced that it has entered into a Securities Purchase Agreement with returning investor, Casdin Partners Master Fund, L.P. managed by Casdin Capital, LLC that it has issued 927,165 shares of common stock of the Company, par value $0.001 per share at a purchase price of $11.19 per share for an aggregate gross proceeds ...Stock analysis for BioLife Solutions Inc (BLFS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.BioLife Sciences Inc. (BLFE.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BioLife Sciences Inc. | OTC Markets: BLFE ...BioLife stock price (as of May 3, 2021) $ 35.07 : Value of issued shares $ 232,741 : plus: Settlement of BioLife prepaid deposits $ 2,152 : plus: Net settlement of BioLife accounts receivable $ 16 : Merger Consideration $ 234,909 .WebBioLife Solutions Return On Equity is currently at (0.23)%. Return on Equity or ROE tells BioLife Solutions stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing BioLife Solutions profitability or the management effectiveness given the capital invested by the shareholders. ROE shows …Get the latest Takeda Pharmaceutical Co Ltd (TAK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Nov 8, 2023 · Biolife Solutions releases figures for Q3 on November 9. Wall Street analysts predict losses per share of $0.364. Go here to track Biolife Solutions stock price in real-time ahead of earnings. Related to this, apart from some occasional sell to cover stock sales transactions to cover taxes for upcoming vesting events, my longstanding portfolio diversification plan sales are now complete. This is a great moment for BioLife and the cell and gene industry in a difficult macro and public market environment.BioLife Solutions Stock Up 7.1 %. Shares of NASDAQ BLFS opened at $13.25 on Monday. BioLife Solutions, Inc. has a one year low of $8.92 and a one year high of $26.89. The company has a debt-to ...Biolife Solutions story: Bona fide gift to Michael Rice of 3000 shares of Biolife Solutions subject to Section 16 and other headlines for Biolife SolutionsFour times named as one of the top 100 Companies to work for in Washington state (2022, 2020, 2015, and 2013), BioLife Solutions Inc. is a multi-platform provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets. Learn more.BioLife Solutions Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time BLFS stock price.Girschweiler sold shares of BioLife stock valued at about $36 million to Casdin Capital LLC in a private transaction, the filing stated. His shares represented a 5% ownership of the BioLife.BioLife Solutions Return On Equity is currently at (0.23)%. Return on Equity or ROE tells BioLife Solutions stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing BioLife Solutions profitability or the management effectiveness given the capital invested by the shareholders. ROE shows …Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Nov 29, 2023 · Complete BioLife Sciences Inc. stock information by Barron's. View real-time BLFE stock price and news, along with industry-best analysis. 2K Salaries (for 270 job titles) • Updated Nov 25, 2023. How much do Biolife Plasma Services employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Our model gets smarter over time as more people ...Sexton acquisition General terms and effects On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation (“Sexton Merger Sub”), Fortis Advisors LLC, in its capacity as the representative of the stockholders of Sexton (the “Sexton Seller Representative”) and …Nov 30, 2023 · No changes to the price of Biolife Sciences Inc stock on the last trading day (Thursday, 30th Nov 2023). During the last trading day the stock fluctuated 100.00% from a day low at $0.0001 to a day high of $0.0002. The price has risen in 4 of the last 10 days and is up by 14900% over the past 2 weeks. Stock Information; Investor Contact; Investor Contact. Media & Investor Relations: Troy Wichterman Chief Financial Officer (425) 402 - 1400 ... BioLife Solutions Inc. 3303 Monte Villa Parkway, Suite 310, Bothell, WA 98021 USA. T +1.866.424.6543 or 425.402.1400 F +1.425.402.1433 E [email protected]. NAVIGATION.WebBioLife will issue 6,646,870 shares of common stock for 100% of the outstanding shares of Stirling in an all-stock transaction, which is expected to close early in the second quarter of 2021. With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted ...Biolife Solutions Cash Flow from Operations is currently at (4.59 M). Operating Cash Flow reveals the quality of Biolife Solutions' reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of …The stock soared from a split-adjusted IPO price of $1.50 per share to $106.69 per share on Dec. 10, 1999. From there, it proceeded to fall 96% until it bottomed on Sept. 28, 2001, at $5.97 per share.BOTHELL, Wash., Nov. 9, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced financial results for the three and nine months …WebBioLife shares outstanding (as of March 19, 2021) 33,401,359 Merger consideration percentage 19.9 % Merger consideration shares 6,646,870 less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI 10,400 Subtotal 6,636,470 BioLife stock price (as of May 3, 2021) $ 35.07 Value of issued shares $ …BioLife Solutions Debt to Equity is currently at 0.06%. Debt to Equity is calculated by dividing the Total Debt of BioLife Solutions by its Equity. If the debt exceeds equity of BioLife. then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of …What really drove the stock down was BioLife's guidance. Management now expects yearly revenue to be between $144 million and $158 million, meaning a drop of between 2% and 11% over 2022.Mar 27, 2023 · BANNOCKBURN, Ill., March 27, 2023--BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of its 200th plasma donation center in the United ... Notes to Financial Statements Business Combination Disclosure [Text Block] 15. Acquisitions Sexton acquisition General terms and effects On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation (“Sexton Merger Sub”), Fortis Advisors LLC, in …BioLife will issue 6,646,870 shares of common stock for 100% of the outstanding shares of Stirling in an all-stock transaction, which is expected to close early in the second quarter of 2021. With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted ...Roderick de Greef appointed Chairman and Chief Executive Officer bringing 20+ years of prior BioLife experience. Garrie Richardson appointed Chief Revenue Officer. Preliminary Q3 revenue of $33.3 million and expect 2023 revenue at the low end of the previously announced guidance range . BOTHELL, Wash., Oct. 19, 2023 /PRNewswire/ - …WebThe estimated total pay for a Quality Manager at Biolife Plasma Services is $86,794 per year. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. ... Additional pay could include bonus, stock, commission, profit sharing or tips. …Dec 4, 2023 · Rhumbline Advisers decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 8.1% in the second quarter, Holdings Channel.com reports. The institutional investor owned 80,251 shares of the medical equipment provider’s stock after selling 7,097 shares during the period. Rhumbline Advisers’ holdings in BioLife Solutions were worth $1,774,000 as of its most recent […] Biolife CBD Gummies helps in reducing your cholesterol level, sugar and blood pressure level and makes you healthy easily. Monday, Nov 27, 2023 ... Stock is limited as compare to demand .BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38 ...Jun 26, 2020 · BLFS. BioLife Solutions, Inc. 11.83. +1.05. +9.74%. The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of ... The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction. See More Share.Conference call begins at 4:30 p.m. Eastern time today . BOTHELL, Wash., Nov. 9, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene therapy (CGT) and broader biopharma markets, today announced financial results for the third quarter ...Nov 24, 2023 · The BioLife Solutions stock price fell by -6.21% on the last day (Wednesday, 18th Oct 2023) from $12.39 to $11.62. During the last trading day the stock fluctuated 5.35% from a day low at $11.59 to a day high of $12.21. The price has fallen in 5 of the last 10 days and is down by -14.5% for this period. Volume fell on the last day along with ... Nov 29, 2023 · Complete BioLife Sciences Inc. stock information by Barron's. View real-time BLFE stock price and news, along with industry-best analysis. 0001354488-12-003014.txt : 20120601 0001354488-12-003014.hdr.sgml : 20120601 20120601150827 accession number: 0001354488-12-003014 conformed submission type: 8-k public document count: 2 conformed period of report: 20120530 item information: entry into a material definitive agreement item information: other events item information: financial …Biolife Solutions story: Bona fide gift to Michael Rice of 3000 shares of Biolife Solutions subject to Section 16 and other headlines for Biolife SolutionsThe estimated net worth of Aby J. Mathew is at least $3.52 million as of November 13th, 2023. Dr. Mathew owns 275,726 shares of BioLife Solutions stock worth more than $3,521,021 as of November 18th. This net worth estimate does not reflect any other assets that Dr. Mathew may own.Biolife Solutions story: Exercise or conversion by Karen Foster of 16332 shares of Biolife Solutions subject to Rule 16b 3 and other headlines for Biolife SolutionsBioLife shares outstanding (as of March 19, 2021) 33,401,359 Merger consideration percentage 19.9 % Merger consideration shares 6,646,870 less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI 10,400 Subtotal 6,636,470 BioLife stock price (as of May 3, 2021) $ 35.07 Value of issued shares $ …See the latest Biolife Sciences Inc stock price (BLFE:PINX), related news, valuation, dividends and more to help you make your investing decisions.Cold Chain Logistics Stocks: BioLife vs Cryoport. Regenerative Medicine. September 20. 2022. 9 mins read. A few months ago, we held a cage match between two of the leading gene-editing stocks. Basically, it ended in a draw, leaving us with a mini portfolio in this potentially lucrative but extremely volatile life sciences /nanotech market.Biolife stock, best platform to trade oil, will medicaid pay for braces in nc
Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to help you make .... Biolife stock
usasBLFS. BioLife Solutions, Inc. 11.83. +1.05. +9.74%. The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of ...BioLife Solutions Stock Performance. BLFS stock opened at $14.08 on Monday. The business has a 50 day moving average of $12.13 and a 200-day moving average of $16.47. BioLife Solutions, Inc. has a 12-month low of $8.92 and a 12-month high of $26.89. The firm has a market cap of $619.96 million, a PE ratio of -5.94 and a beta of 1.57.View BioLife Solutions, Inc BLFS investment & stock information. Get the latest BioLife Solutions, Inc BLFS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.WebNo changes to the price of Biolife Sciences Inc stock on the last trading day (Thursday, 30th Nov 2023). During the last trading day the stock fluctuated 100.00% from a day low at $0.0001 to a day high of $0.0002. The price has risen in 4 of the last 10 days and is up by 14900% over the past 2 weeks.View the latest BioLife Sciences Inc. (BLFE) stock price, news, historical charts, analyst ratings and financial information from WSJ. Rhumbline Advisers decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 8.1% in the second quarter, Holdings Channel.com reports. The institutional investor owned 80,251 shares of the medical equipment provider’s stock after selling 7,097 shares during the period. Rhumbline Advisers’ holdings in …WebBiolife Solutions stock has received a consensus rating of buy. The average rating score is and is based on 8 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Biolife ...Biolife Solutions Cash and Equivalents vs. Debt to Equity. Stocks . USA .. Stock . Biolife SolutionsMar 27, 2023 · BANNOCKBURN, Ill., March 27, 2023--BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of its 200th plasma donation center in the United ... BOTHELL, WA—June 1, 2012—BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, ... the Company and understand that the near-term maturity of debt was seen as an overhang for potential new investors in BioLife stock. The extension of the maturity date until 2016, gives us time and financial flexibility to execute on our current growth ...Notes to Financial Statements Business Combination Disclosure [Text Block] 15. Acquisitions Sexton acquisition General terms and effects On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation (“Sexton Merger Sub”), Fortis Advisors LLC, in …BOTHELL, Wash., Sept. 1, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed its acquisition of Sexton Biotechnologies.REVENUE. Total revenue for the third quarter of 2022 was $40.7 million, an increase of $6.9 million, or 21%, from $33.8 million for the third quarter of 2021. Organic revenue growth was 18%. COVID-19 related revenue was approximately 9%, compared with approximately 18% in Q3 2021.Dec 1, 2023 · BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking. BioLife Solutions, Inc. | 6,162 followers on LinkedIn. A leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies | BioLife Solutions is a ...Exact matches only . Search in title. Search in titleBiolife Solutions Return On Asset is currently at (5.67)%. Return on Asset or ROA shows how effective is the management of the Biolife Solutions in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of Biolife Solutions as well as to understand management …See BioLife Solutions, Inc. (BLFS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. B. Riley FBR analyst Marc Wiesenberger resumed coverage of BioLife stock with a Buy rating and a price target of $27 per share, representing a 94.6% premium to Thursday's closing price. As cell ...WebJan 6, 2023 · The stock seems fairly valued at the moment according to my valuation model. It’s trading around 20% below my intrinsic value, which means if you buy BioLife Solutions today, you’d be paying a ... BioLife Solutions Inc (NASDAQ:BLFS). 12.77. Delayed Data. As of Nov 17. +0.81 / + ... Most stock quote data provided by BATS. Market indices are shown in real ...Biolife Solutions story: Bona fide gift to Michael Rice of 3000 shares of Biolife Solutions subject to Section 16 and other headlines for Biolife SolutionsGet the latest BioLife Solutions, Inc. (BLFS) stock quote, history, news and other vital information to help you with your stock trading and investing. See the company's …Operating income, quarterly and annual stats of BIOLIFE SOLUTIONS DL ... Stock Screener · Forex Screener · Crypto Pairs Screener · Crypto Coins Screener ...BOTHELL, Wash., Jan. 5, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction ...WebAug 9, 2023 · What really drove the stock down was BioLife's guidance. Management now expects yearly revenue to be between $144 million and $158 million, meaning a drop of between 2% and 11% over 2022. In Stock . Qty: Qty: 1 $ $18.99 18. 99 () Includes selected options. Includes initial monthly payment and selected options. ... and herbs. Biolife provides the perfect amount of vitamins, minerals, antioxidants, and herbs. Biolife helps to bridge the nutrient gap in your diet. It offers immune support, increased energy, and mental alertness by ...BIOLIFE : B Riley Raises BioLife Solutions' PT to $61 from $35.50 After Q4 Revenue Beats Street, Announces Stirling Ultracold Deal; Keeps Buy Rating 2021: MT BIOLIFE : Maxim Adjusts Price Target on BioLife Solutions to $60 From $40, Maintains Buy Rating 2021: MTFind the latest BioLife Sciences Inc. (BLFE) stock quote, history, news and other vital information to help you with your stock trading and investing. Nov 30, 2023 · BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.WebCasdin Capital now owns about 19.5% of BioLife Solutions' stock. BioLife Chief Financial Officer Troy Wichterman said the company didn't have any insight to provide beyond the publicly available ...See BioLife Solutions, Inc. (BLFS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.BioLife Solutions, Inc. (Name of Issuer). Common Stock, $0.001 par value. (Title of Class of Securities) ...The estimated total pay for a Quality Manager at Biolife Plasma Services is $86,794 per year. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. ... Additional pay could include bonus, stock, commission, profit sharing or tips. …Nov 30, 2023 · No changes to the price of Biolife Sciences Inc stock on the last trading day (Thursday, 30th Nov 2023). During the last trading day the stock fluctuated 100.00% from a day low at $0.0001 to a day high of $0.0002. The price has risen in 4 of the last 10 days and is up by 14900% over the past 2 weeks. 20 ก.ย. 2565 ... Cryoport probably gets the edge thanks to its larger size and international presence. While it also has a better (not great) gross margin, ...BIOLIFE4D IPO Registration Document (S-1) BIOLIFE4D has filed to go public with an IPO on the NASDAQ. 1 year ago - SEC. Get the latest BioLife4D Corporation (SAVU) stock price quote with news, financials, IPO details and other important investing information.BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38 ... 5 Wall Street analysts have issued 1 year target prices for BioLife Solutions' stock. Their BLFS share price targets range from $22.00 to $28.00. On average, they expect the company's stock price to reach $24.60 in the next year. This suggests a possible upside of 91.7% from the stock's current price. View analysts price targets for BLFS or ... BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.Biolife Solutions Working Capital is currently at 5.25 M. Working Capital is a measure of Biolife Solutions efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .BOTHELL, Wash., April 6, 2021 / PRNewswire / -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has appointed Amy DuRoss, chief executive officer of Vineti, and Rachel ...WebBOTHELL, Wash., April 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an …According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.Dec 4, 2023 · BioLife Solutions Stock Up 7.1 %. Shares of NASDAQ BLFS opened at $13.25 on Monday. BioLife Solutions, Inc. has a one year low of $8.92 and a one year high of $26.89. The company has a debt-to ... Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to …biolife sciences inc. biolife sciences inc. 0.00 -11.11% 0.0004 . Raymond james fees, best dividend reit